<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang Q</submitter><funding>Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan</funding><pagination>14811</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11208498</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Ischemic heart diseases are a major global cause of death, and despite timely revascularization, heart failure due to ischemia-hypoxia reperfusion (IH/R) injury remains a concern. The study focused on the role of Early Growth Response 1 (EGR1) in IH/R-induced apoptosis in human cardiomyocytes (CMs). Human induced pluripotent stem cell (hiPSC)-derived CMs were cultured under IH/R conditions, revealing higher EGR1 expression in the IH/R group through quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting (WB). Immunofluorescence analysis (IFA) showed an increased ratio of cleaved Caspase-3-positive apoptotic cells in the IH/R group. Using siRNA for EGR1 successfully downregulated EGR1, suppressing cleaved Caspase-3-positive apoptotic cell ratio. Bioinformatic analysi</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes.</pubmed_title><pmcid>PMC11208498</pmcid><funding_grant_id>20K09125</funding_grant_id><pubmed_authors>Minatoya K</pubmed_authors><pubmed_authors>Masumoto H</pubmed_authors><pubmed_authors>Murata K</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Ikeda T</pubmed_authors></additional><is_claimable>false</is_claimable><name>miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes.</name><description>Ischemic heart diseases are a major global cause of death, and despite timely revascularization, heart failure due to ischemia-hypoxia reperfusion (IH/R) injury remains a concern. The study focused on the role of Early Growth Response 1 (EGR1) in IH/R-induced apoptosis in human cardiomyocytes (CMs). Human induced pluripotent stem cell (hiPSC)-derived CMs were cultured under IH/R conditions, revealing higher EGR1 expression in the IH/R group through quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting (WB). Immunofluorescence analysis (IFA) showed an increased ratio of cleaved Caspase-3-positive apoptotic cells in the IH/R group. Using siRNA for EGR1 successfully downregulated EGR1, suppressing cleaved Caspase-3-positive apoptotic cell ratio. Bioinformatic analysi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-20T02:15:00.414Z</modification><creation>2025-04-20T02:15:00.414Z</creation></dates><accession>S-EPMC11208498</accession><cross_references><pubmed>38926457</pubmed><doi>10.1038/s41598-024-65373-x</doi></cross_references></HashMap>